University of Glasgow teams up with Eli Lilly and Company for research on immunological diseases, including arthritis
By Ian McConnell
Source: heraldscotland.com
Stay updated with breaking news from Stefan Siebert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Search jobs UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate the next generation of drug targets for immunological diseases. The £4.6million research collaboration, due to last four years, will work across four diseases – psoriatic arthritis, rheumatoid arthritis, fibrosis and vasculitis – and will be led by the University of Glasgow’s Institute of Infection, Immunity and...